MedTrace Logo

Laryngeal Mask Airway Supreme Versus Laryngeal Tube

NCT02252120 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-09-29

No results posted yet for this study

Summary

The investigators test the hypothesis that oropharyngeal leak pressure and fiberoptic position differ between the size 2 LMA SupremeTM and the Laryngeal Tube LTS IITM in non-paralyzed anaesthetized pediatric patients

Conditions

  • Adverse Anesthesia Outcome

Interventions

DEVICE

Supreme

DEVICE

Laryngeal Tube

Sponsors & Collaborators

  • University of Salzburg

    collaborator OTHER

  • Schulthess Klinik

    lead OTHER

Principal Investigators

  • Christian Keller, MD, M.Sc. · Schulthess Klinik, Lengghalde 2, 8008 Zürich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Months
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-09-30
Completion
2014-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02252120 on ClinicalTrials.gov